Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for par… Read more
Molecular Data Inc. (MKDTY) - Total Liabilities
Latest total liabilities as of September 2021: $681.45 Million USD
Based on the latest financial reports, Molecular Data Inc. (MKDTY) has total liabilities worth $681.45 Million USD as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Molecular Data Inc. - Total Liabilities Trend (2017–2020)
This chart illustrates how Molecular Data Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Molecular Data Inc. Competitors by Total Liabilities
The table below lists competitors of Molecular Data Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WING TAI PROP (USH.SG)
STU:USH
|
Germany | €7.81 Billion |
|
Missfresh Limited
PINK:MFLTY
|
USA | $1.71 Billion |
|
Americann Inc
PINK:ACAN
|
USA | $6.99 Million |
Liability Composition Analysis (2017–2020)
This chart breaks down Molecular Data Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Molecular Data Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Molecular Data Inc. (2017–2020)
The table below shows the annual total liabilities of Molecular Data Inc. from 2017 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | $712.70 Million | +64.51% |
| 2019-12-31 | $433.22 Million | 0.00% |
| 2018-12-31 | $433.22 Million | +15.45% |
| 2017-12-31 | $375.25 Million | -- |